GlassScriptPhysician profile
Dominic P Amara
NPI 1518958313
$1,453.98
in general payments reported to CMS, 2019-2025
12 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $65.70 · 2021: $138 · 2022: $257 · 2023: $318 · 2024: $292 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574 · Education: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.00 |
| Education | $213.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $537.59 | 2022-2024 | Veozah, Myrbetriq |
| Organon LLC | $260.77 | 2021-2025 | Nexplanon |
| Abbvie INC. | $141.01 | 2019-2020 | |
| Pfizer INC. | $104.60 | 2022-2023 | |
| Therapeuticsmd, INC. | $80.66 | 2019-2021 | |
| Medtronic, INC. | $72.86 | 2025 | Signia |
| Amag Pharmaceuticals, INC. | $72.30 | 2019 | |
| Hologic Sales and Service, LLC | $65.87 | 2024-2025 | Myosure Tissue Removal Device, Novasure |
| Myovant Sciences INC. | $42.79 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $25.67 | 2021 | |
| Biogen, INC. | $24.93 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $24.93 | 2022-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dominic Amara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.